Iridium-Catalyzed Selective α-Alkylation of Unactivated Amides with Primary Alcohols
摘要:
The first a-alkylation of unactivated amides with primary alcohols is described. An effective and robust iridium pincer complex has been developed for selective alpha-alkylation of tertiary and secondary acetamides involving a "borrowing hydrogen" methodology. The method is compatible with alcohols bearing various functional groups. This presents a convenient and environmentally benign protocol for alpha-alkylation of amides.
ANTIBODIES, COMPOUNDS AND SCREENS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA
申请人:The Broad Institute Inc.
公开号:EP3822291A1
公开(公告)日:2021-05-19
The invention provides therapeutic, engineered protein/peptide compositions comprising e.g., RAGE antibodies, T-cell receptors to target a RAGE receptor (including soluble forms thereof) directly and/or via differential competition with one or more pre-cachexia and/or cachexia-associated RAGE ligands or markers.
The first a-alkylation of unactivated amides with primary alcohols is described. An effective and robust iridium pincer complex has been developed for selective alpha-alkylation of tertiary and secondary acetamides involving a "borrowing hydrogen" methodology. The method is compatible with alcohols bearing various functional groups. This presents a convenient and environmentally benign protocol for alpha-alkylation of amides.